US: NVA to split into two groups with plans to IPO
Global pet care organization, National Veterinary Associates (NVA), is forming two distinct businesses - Ethos Veterinary Health (Ethos), which will consist of 145 specialty...
Inner Mongolia: CS Medica secures investment from Inner Mongolia Rong Shi Hi-Tech and creates...
CS Medica, a Denmark-based medtech company operating within research, development, manufacturing, commercializing, and a part of the pharmaceutical industry, has entered into an agreement...
Belgium: Georges Rawadi appointed as CEO of Celyad Oncology
Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, has appointed Georges Rawadi as its new CEO....
Norway: Observe Medical secures new financing for short term needs
Nordic medtech company, Observe Medical, has entered into loan agreements of NOK10m (US$960,000) with its largest shareholders to cover short-term financing needs. The company...
UK: Kester Capital backs MBO of MAP
Kester Capital, a UK-based lower mid-market private equity specialist, has invested in MAP Patient Access, a market access consulting service to the pharmaceutical and...
Sweden: Palette turns to OrbiMed for debt facility in wake of SVB collapse
Global life sciences company, Palette Life Sciences, has signed a debt financing facility for up to US$75m with healthcare investor, OrbiMed. The non-dilutive capital...
UAE: ADQ integrates Acino with Pharmax
Acino, a Swiss pharmaceutical company and part of ADQ, an Abu Dhabi based investment and holding company, has integrated with another ADQ company, Pharmax...
Funding round-up: Vitestro, Sunrise, Fire1, Seamless Therapeutics
Germany: Seamless Therapeutics, a biotech company, has raised a US$12.5m in a seed financing round that will accelerate development of its designer recombinases, a...
Australia: ACL makes off-market bid for Healius
Healius, Australia’s second-largest pathology provider and third-largest diagnostic imaging provider, is the target of an off-market takeover bid from the country’s third largest private...
Australia: Brandon BioCatalyst and ANDHealth selected for BMTI programme
Brandon BioCatalyst, in partnership with ANDHealth, has been selected by the Australian Federal Government to deliver the A$50m (US$33.3m) BioMedTech Incubator (BMTI) programme.
The investment, from...
©2023 All rights reserved LaingBuisson 
